0001140361-18-032341.txt : 20180713 0001140361-18-032341.hdr.sgml : 20180713 20180713133651 ACCESSION NUMBER: 0001140361-18-032341 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180711 FILED AS OF DATE: 20180713 DATE AS OF CHANGE: 20180713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sofia Michael J. CENTRAL INDEX KEY: 0001635324 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34949 FILM NUMBER: 18952180 MAIL ADDRESS: STREET 1: C/O ONCORE BIOPHARMA, INC. STREET 2: 3805 OLD EASTON ROAD CITY: DOYLESTOWN STATE: PA ZIP: 18902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arbutus Biopharma Corp CENTRAL INDEX KEY: 0001447028 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 980597776 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 BUSINESS PHONE: 604-419-3200 MAIL ADDRESS: STREET 1: 100-8900 GLENLYON PARKWAY CITY: BURNABY STATE: A1 ZIP: V5J 5J8 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS Corp DATE OF NAME CHANGE: 20110607 FORMER COMPANY: FORMER CONFORMED NAME: TEKMIRA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20081003 4 1 doc1.xml FORM 4 X0306 4 2018-07-11 0 0001447028 Arbutus Biopharma Corp ABUS 0001635324 Sofia Michael J. C/O ARBUTUS BIOPHARMA CORP. SUITE 100, 8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 BRITISH COLUMBIA, CANADA 0 1 0 0 Chief Scientific Officer Common Shares 2018-07-11 4 S 0 10000 10.00 D 1503403 D Common Shares 171412 I Held by Irrevocable Deed of Trust of Michael J. Sofia dated December 22, 2014 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2017. /s/ David C. Hastings, attorney-in-fact for Michael J. Sofia 2018-07-13